| Date Filed | Type | Description |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 0% stake in Ocera Therapeutics, Inc. |
| 12/21/2017 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 12/14/2017 |
SC 13D/A
| Domain Partners VIII, L.P. reports a 0% stake in Ocera Therapeutics, Inc. |
| 12/14/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/14/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/14/2017 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/11/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/11/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/11/2017 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/11/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/11/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/11/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/11/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/11/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/11/2017 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/11/2017 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 12/11/2017 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 12/11/2017 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 12/11/2017 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 12/07/2017 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against Ocera Therapeutics, Inc. |
| 12/01/2017 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/20/2017 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/20/2017 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/16/2017 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/14/2017 |
10-Q
| Quarterly Report for the period ended September 30, 2017 |
| 11/13/2017 |
SC 13D
| Mallinckrodt plc reports a 12.7% stake in Ocera Therapeutics, Inc. |
| 11/09/2017 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 11/09/2017 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 11/02/2017 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 11/02/2017 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 11/02/2017 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 11/02/2017 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulat...|
Docs:
|
"Agreement and Plan of Merger, by and among Ocera Therapeutics, Inc., MAK LLC, MEH Acquisition Co., and for limited purposes, Mallinckrodt plc",
"Amendment to Bylaws of the Company",
"Form of Tender and Support Agreement",
"MALLINCKRODT TO ACQUIRE OCERA THERAPEUTICS AND OCR-002, ITS PROPRIETARY THERAPY IN DEVELOPMENT FOR TREATMENT OF HEPATIC ENCEPHALOPATHY" |
|
| 11/02/2017 |
GN
| Mallinckrodt to Acquire Ocera Therapeutics and OCR-002, its Proprietary Therapy in Development for Treatment of Hepatic Encephalopathy |
|